Compartilhar
Informação da revista
Vol. 94. Núm. 5.
Páginas 624-626 (1 setembro 2019)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
5648
Vol. 94. Núm. 5.
Páginas 624-626 (1 setembro 2019)
Case Letter
Open Access
Neurofibromatosis with vitiligo: an uncommon association rather than coexistence?
Visitas
5648
Sidharth Tandon, Ajeet Singh
Autor para correspondência
a.ajityadav@gmail.com

Corresponding author.
, Pooja Arora, Ram Krishan Gautam
Dermatology Department, PGIMER& Dr. Ram Manohar Lohia Hospital, New Delhi, India
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (2)
Tabelas (1)
Table 1. Previously reported cases of type 1 neurofibromatosis (NF1) associated with vitiligo.
Texto Completo
Dear Editor,

Type 1 neurofibromatosis (NF1) is an autosomal dominant multisystem disease caused by a mutation in the neurofibromin 1 gene which affects tissues derived from the neural crest.1 Clinically, it is characterized by a spectrum of defects comprising of neural tumors, cafe-au-lait spots, intertriginous freckling, and skeletal defects. Generalized vitiligo has rarely been reported with neurofibromatosis. Here, we present two cases of NF1 associated with vitiligo and showing the halo phenomenon in neurofibromas.

A 28-year-old male patient who was a known case of NF1 presented with multiple depigmented patches on the skin, which had started developing in the last four years. His family history revealed that his mother also had neurofibromatosis, with no history of any depigmented lesions. Dermatological examination revealed multiple well-demarcated, light-brown macules of size varying from 5 to 50mm present over the trunk, back, and upper limbs. Numerous sessile as well as pedunculated dome-shaped papulonodular lesions of varying sizes, suggestive of neurofibromas, were present over the face, trunk, back, and upper limbs. Some of these lesions were encircled by a depigmented halo. Sharply defined depigmented patches, consistent with a diagnosis of vitiligo and varying between 2 and 7cm in size, were present over back, elbows, and dorsum of hands and feet (Fig. 1). Bilateral axillary freckling was also seen. Slit lamp examination of iris showed the presence of Lisch nodules. Dermoscopy of the vitiligo lesion showed reduced pigmentary network as compared to normal skin (Fig. 2).

Figure 1.

Café-au-lait macules, neurofibromas with perilesional halo, and vitiligo patches over the back.

(0.06MB).
Figure 2.

Border of a lesion on dermoscopy, showing reduced pigmentary network in the lesion compared to normal skin.

(0.09MB).

The second case was a 35-year-old male patient; a known case of neurofibromatosis presented with depigmented patches involving the normal skin and the skin surrounding the neurofibromas over the previous year. There was a family history of neurofibromatosis in his father and brother. On cutaneous examination, multiple dome-shaped, skin colored papulonodular lesions of variable sizes and soft in consistency were present over the face, trunk, back, and extremities. Some nodules had depigmented halo around them. Multiple well-demarcated, light brown colored patches, 5–20mm in size, were present over back, chest and upper extremities. Sharply demarcated patches of depigmentation suggestive of vitiligo, along with freckles, were present in both the axilla and over the trunk and back. Dermoscopy of the lesion showed reduced pigmentary network.

NF1 is one of the most common autosomal dominant neurocutaneous disorder, with an estimated prevalence of around 1 in 3500 individuals. It has a highly variable clinical expression and approximately 30–50% of all patients lack a family history of the disease, representing de novo mutations of the NF1 gene.

Friedrich Von Recklinghausen was the first to describe the classical features of the disease and pointed out that the origin of the skin tumor was from peripheral nerves. Café-au-lait macules (CALMs) which are the first sign of NF1, signify the collection of heavily pigmented melanocytes originating from the neural crest in the epidermis. Ninety-five percent of patients of NF1 have CALMs by the time they reach the adulthood. Regarding the pigmentary changes, it was suggested that since the pigment producing melanocyte originates in the neural crest, the presence of pigmentary lesions due to changes in melanocyte cell growth and differentiation can be expected. Cell culture studies have shown that the NF1 gene defect affects melanogenesis in the epidermal melanocytes of NF1 patients, resulting in the various hyperpigmentary changes seen in NF1.2

The halo phenomenon signifies the sudden development of a depigmented halo around a congenital nevus, Spitz nevus, blue nevus, neurofibromas, and malignant melanomas. Shin et al.3 described a case of naevus combined with vitiliginous changes and speculated that the immunological process involved in vitiligo simultaneously affected the underlying dermal naevus cells, causing their degeneration. Gach et al.4 pointed out that clinical and histological similarity between the congenital melanocytic nevi and neurofibromas was because of the fact that both melanocytes and Schwann cells originate from the neural crest (Table 1). The levels of chronically activated CD8+ T-cells are increased in NF1 patients, which provides further evidence that the halo phenomenon in neurofibromas in the presence of generalized vitiligo develops as an immunological response.5

Table 1.

Previously reported cases of type 1 neurofibromatosis (NF1) associated with vitiligo.

Year  Author  Type of NF  Type of vitiligo  Associated halo phenomenon  Other associated features 
1992  Singh et al.  NF1  Generalized  Absent   
2006  Oiso et al.  NF1  Generalized  Present   
2006  Bukhari et al.  NF1  Generalized  Absent  Left occipital bone defect 
2006  Yalccin et al.  NF1  Generalized  Absent  Hashimoto's thyroiditis, Noonan syndrome 
2008  Nanda  NF1  Generalized  Absent   
2016  Duman et al.  NF1  Generalized  Absent  Inferior chorioretinal coloboma and optic disc pseudo-doubling in the right eye 
2016  Reinehr et al.  NF1  Acral  Absent   
2018  Present  NF1  Generalized  Present   

A thorough review of the literature yielded the following cases of neurofibromatosis associated with vitiligo as described in table 1. The sudden appearance of the halo phenomenon in patients of neurofibromatosis should not be treated as a mere co-existence, but as a marker of a much more sinister association between neurofibromatosis and vitiligo. We recommend that further studies should be carried out to provide a greater insight into this complex association.

Financial support

None.

Author's contribution

Sidharth Tandon and Pooja Arora: Approval of the final version of the manuscript; elaboration and writing of the manuscript; critical review of the literature; critical review of the manuscript.

Ajeet Singh: Approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing and interpreting the data; effective participation in research orientation; critical review of the literature; critical review of the manuscript.

Ram Krishan Gautam: Critical review of the literature; critical review of the manuscript.

Conflicts of interest

The authors declare no conflicts of interest.

References
[1]
A. Theos, B.R. Korf, American College of Physicians; American Physiological Society.
Pathophysiology of neurofibromatosis type 1.
[2]
D. Kaufmann, S. Wiandt, J. Veser, W. Krone.
Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF1).
Hum Genet, 87 (1991), pp. 144-150
[3]
J.H. Shin, M.J. Kim, S. Cho, K.K. Whang, J.H. Hahm.
A case of giant congenital nevocytic nevus with neurotization and onset of vitiligo.
J Eur Acad Dermatol Venereol, 16 (2002), pp. 384-386
[4]
J.E. Gach, R.A. Carr, R. Charles-Holmes, S. Harris.
Multiple congenital melanocytic naevi presenting with neurofibroma-like lesions complicated by malignant melanoma.
Clin Exp Dermatol, 29 (2004), pp. 473-476
[5]
S. Karmakar, K.M. Reilly.
The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.
CNS Oncol, 6 (2017), pp. 45-60

Please cite this article as: Tandon S, Singh A, Arora P, Gautam RK. Neurofibromatosis with vitiligo: an uncommon association rather than coexistence? An Bras Dermatol. 2019;94:624–6.

Study conducted at the Dermatology Department, Dr. Ram Manohar Lohia Hospital, New Delhi, India.

Copyright © 2019. Sociedade Brasileira de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.